Does fecal calprotectin predict short-term relapse after stopping TNFα-blocking agents in inflammatory bowel disease patients in deep remission?
The study examined whether elevated fecal calprotectin (FC) concentrations after stopping TNFα-blocking therapy can predict clinical or endoscopic relapse. Patients relapsing showed constantly elevated FC levels for a median of 94 (13-317) days before the relapse
